BR112014007022A2 - composição farmacêutica para melhoria de absorção do trato gastrointestinal - Google Patents

composição farmacêutica para melhoria de absorção do trato gastrointestinal

Info

Publication number
BR112014007022A2
BR112014007022A2 BR112014007022A BR112014007022A BR112014007022A2 BR 112014007022 A2 BR112014007022 A2 BR 112014007022A2 BR 112014007022 A BR112014007022 A BR 112014007022A BR 112014007022 A BR112014007022 A BR 112014007022A BR 112014007022 A2 BR112014007022 A2 BR 112014007022A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
gastrointestinal tract
improving gastrointestinal
tract absorption
absorption
Prior art date
Application number
BR112014007022A
Other languages
English (en)
Other versions
BR112014007022A8 (pt
BR112014007022B1 (pt
Inventor
Hartle Jennifer
Bortz Jonathan
Original Assignee
Amip
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amip filed Critical Amip
Publication of BR112014007022A2 publication Critical patent/BR112014007022A2/pt
Publication of BR112014007022A8 publication Critical patent/BR112014007022A8/pt
Publication of BR112014007022B1 publication Critical patent/BR112014007022B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/295Iron group metal compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112014007022-9A 2011-09-22 2012-09-24 composição farmacêutica, método e uso de uma composição farmacêutica BR112014007022B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161538028P 2011-09-22 2011-09-22
US61/538,028 2011-09-22
PCT/US2012/056944 WO2013044246A1 (en) 2011-09-22 2012-09-24 Buffered upper gi absorption promoter
US13/625,652 US20130209577A1 (en) 2011-09-22 2012-09-24 Buffered Upper GI Absorption Promoter
US13/625,652 2012-09-24

Publications (3)

Publication Number Publication Date
BR112014007022A2 true BR112014007022A2 (pt) 2017-04-25
BR112014007022A8 BR112014007022A8 (pt) 2018-01-09
BR112014007022B1 BR112014007022B1 (pt) 2021-02-09

Family

ID=47914954

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014007022-9A BR112014007022B1 (pt) 2011-09-22 2012-09-24 composição farmacêutica, método e uso de uma composição farmacêutica

Country Status (7)

Country Link
US (1) US20130209577A1 (pt)
AU (4) AU2012311964B2 (pt)
BR (1) BR112014007022B1 (pt)
CA (1) CA2849732C (pt)
MX (1) MX2014003327A (pt)
WO (1) WO2013044246A1 (pt)
ZA (1) ZA201402197B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014275307B2 (en) * 2013-06-06 2017-06-15 Amip, Llc Iron supplement
GB201416293D0 (en) * 2014-09-15 2014-10-29 Solvotrin Therapeutics Ltd Methods and preparations
US11224615B2 (en) * 2016-03-15 2022-01-18 Solvotrin Therapeutics Ltd Compositions and methods for increasing iron intake in a mammal

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716814B2 (en) * 2001-08-16 2004-04-06 Albion International, Inc. Enhancing solubility of iron amino acid chelates and iron proteinates
US7371422B2 (en) * 2003-05-13 2008-05-13 The Procter & Gamble Company Cereal grain kernels fortified with iron and calcium
US20090035385A1 (en) * 2004-12-22 2009-02-05 Drugtech Corporation Compositions including iron
US20060134227A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron
US8007846B2 (en) * 2006-01-18 2011-08-30 Albion International, Inc. Mixed amino acid/mineral compounds having improved solubility
US8287848B2 (en) * 2006-10-03 2012-10-16 Tris Pharma Inc Formulations containing an ionic mineral-ion exchange resin complex and uses thereof
ITMI20071979A1 (it) * 2007-10-12 2009-04-13 Massimo Baldacci Formulazioni farmaceutiche contenenti ferro bisglicinato chelato
US20090124572A1 (en) * 2007-11-09 2009-05-14 Deanna Jean Nelson Iron-containing nutritional supplement
IT1398291B1 (it) * 2009-12-16 2013-02-22 Baldacci Lab Spa Ferro bisglicinato chelato per uso nel trattamento per via orale dell'anemia in pazienti celiaci.

Also Published As

Publication number Publication date
AU2016277587A1 (en) 2017-01-12
AU2018286568A1 (en) 2019-01-24
ZA201402197B (en) 2015-11-25
AU2012311964B2 (en) 2016-09-22
CA2849732C (en) 2019-10-01
BR112014007022A8 (pt) 2018-01-09
CA2849732A1 (en) 2013-03-28
AU2020277247A1 (en) 2020-12-24
AU2018286568B2 (en) 2020-09-03
AU2020277247B2 (en) 2023-01-05
MX2014003327A (es) 2014-07-09
BR112014007022B1 (pt) 2021-02-09
AU2016277587B2 (en) 2018-10-04
AU2012311964A1 (en) 2013-05-02
US20130209577A1 (en) 2013-08-15
WO2013044246A1 (en) 2013-03-28

Similar Documents

Publication Publication Date Title
SMT201700008B (it) Composizione farmaceutica
DK2694038T3 (da) Farmaceutisk sammensætning
CO6852076A2 (es) Composiciones farmacéuticas inhalables
DK3246018T3 (da) Farmaceutisk sammensætning
BRPI1008598A2 (pt) composição farmacêutica para inalação
BR112014003052A2 (pt) composições farmacêuticas
IT1394860B1 (it) Composti farmaceutici
CO6930367A2 (es) Composiciones farmaceúticas
EE201300005A (et) Ravimkoostis
GB201118232D0 (en) Pharmaceutical composition
BR112012004080A2 (pt) composições farmacêuticas para tratar ibd
BR112013008074A2 (pt) combinações farmacêuticas
SMT201500005B (it) Composizione framaceutica inalabile
BR112014009319A2 (pt) compostos farmacêuticos
HK1189158A1 (en) Pharmaceutical composition
IT1393930B1 (it) Composti farmaceutici
BR112014015885A8 (pt) preparação farmacêutica
BR112012026860A2 (pt) composição farmacêutica sólida para neutralizar ácido estomacal
BR112012029461A2 (pt) composição farmacêutica contendo solifenacina
EP2689777A4 (en) PHARMACEUTICAL COMPOSITION FOR TREATING HEPATIC DISEASES
IT1395724B1 (it) Composti farmaceutici
BR112014007022A2 (pt) composição farmacêutica para melhoria de absorção do trato gastrointestinal
EP2727593A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING NICORANDIL
EP2606910A4 (en) PHARMACEUTICAL COMPOSITION FOR TRANSCOLIC ABSORPTION
EP2711010A4 (en) PHARMACEUTICAL COMPOSITION

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/09/2012, OBSERVADAS AS CONDICOES LEGAIS.